Intraventricular treatment of relapsed and refractory central nervous system (CNS) lymphoma with rituximab.

被引:0
|
作者
Schulz, H
Pels, H
Hom, E
Thall, A
Engert, A
机构
[1] Univ Cologne, Clin Internal Med 1, Cologne, Germany
[2] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany
[3] Idec Pharmaceut Corp, Clin Immunol, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4725
引用
收藏
页码:249B / 249B
页数:1
相关论文
共 50 条
  • [21] The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
    Van Dijck, Ruben
    Doorduijn, Jeanette K.
    Bromberg, Jacoline E. C.
    [J]. CANCERS, 2021, 13 (08)
  • [22] Post-transplant lymphoproliferative disorders involving the central nervous system (CNS-PTLD): Therapy with rituximab.
    Ghobrial, IM
    Habermann, TM
    Ristow, K
    Ansell, SM
    McGregor, CG
    O'Neill, BP
    [J]. BLOOD, 2003, 102 (11) : 297B - 298B
  • [23] Intraventricular primary central nervous system lymphoma
    Guedes, LC
    Barroso, C
    Ruivo, N
    Pimentel, JG
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 68 - 68
  • [24] SALVAGE CHEMOTHERAPY WITH TEMOZOLOMIDE IN REFRACTORY OR RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Makino, Keishi
    Nakamura, Hideo
    Hide, Takuichiro
    Kuratsu, Jun-ichi
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 916 - 916
  • [25] Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma
    Voloschin, Alfredo D.
    Betensky, Rebecca
    Wen, Patrick Y.
    Hochberg, Fred
    Batchelor, Tracy
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (02) : 211 - 215
  • [26] Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma
    Alfredo D. Voloschin
    Rebecca Betensky
    Patrick Y. Wen
    Fred Hochberg
    Tracy Batchelor
    [J]. Journal of Neuro-Oncology, 2008, 86 : 211 - 215
  • [27] Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan
    Fischer, L
    Thiel, E
    Klasen, HA
    Kirchen, H
    Jahnke, K
    Korfel, A
    [J]. NEUROLOGY, 2004, 62 (10) : 1885 - 1887
  • [28] Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status
    Keishi Makino
    Hideo Nakamura
    Taku-ichiro Hide
    Jun-ichi Kuratsu
    [J]. Journal of Neuro-Oncology, 2012, 106 : 155 - 160
  • [29] Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status
    Makino, Keishi
    Nakamura, Hideo
    Hide, Taku-Ichiro
    Kuratsu, Jun-Ichi
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (01) : 155 - 160
  • [30] Efficacy and Safety of Pemetrexed Combined with Lenalidomide in the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma
    Ma, Jingjing
    Chen, Bobin
    Zhiguang, Lin
    Li, Qing
    Kang, Hui
    Ma, Yan
    [J]. BLOOD, 2020, 136